# Novo Nordisk (NVO) announced on Friday that an expert panel of the European Medicines Agency, the EU drug regulator, endorsed a single-dose pen.

*biotech · news · 2026-05-22 · Seeking Alpha*

## Key points

- Novo Nordisk received EMA panel endorsement for a 7.2 mg single-dose pen of Wegovy.
- This is the first time a 7.2 mg version of Wegovy is being recommended in the EU.
- The EMA's Committee issued a positive opinion specifically for the single-dose pen format.
- This regulatory endorsement could expand treatment options and ease of use for obesity patients in Europe.

**Companies:** Novo Nordisk A/S
**Countries:** Denmark

[Read the full story on Seeking Alpha](https://seekingalpha.com/news/4596414-novo-gets-eu-backing-higher-dose-wegovy-single-dose-pen)

---

Canonical: https://newsio.io/n/24cd1893-dcd1-4cb8-9d50-3a7d1b24f4fc/novo-nordisk-nvo-announced-on-friday-that-an-expert-panel-of-the-european-medici
Summarized by Newsio from Seeking Alpha. https://newsio.io/how-it-works